The effect of antiaggregational therapy on the long-term patency of the femoropopliteal/crural bypass
Author(s) -
Dragan Vasić,
Oliver Radmili,
Lazar Davidović,
Milica Vranes
Publication year - 2012
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh1202029v
Subject(s) - medicine , ticlopidine , surgery , thrombosis , popliteal artery , significant difference , medium term , aspirin , economics , clopidogrel , macroeconomics
Antiaggregational therapy can reduce thrombosis development following the arterial reconstruction surgery. In most cases acetylsalicylic acid and ticlopidine are used as antiaggregational agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom